Focused Alpha’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Focused Alpha's LLY Position: Q3 2026 in Review
Focused Alpha increased its Eli Lilly (LLY) stake by 142% in Q3 2026, buying an estimated $681K and bringing the position to 983 shares worth $1.14M. The position accounts for 0.28% of the portfolio, ranked #60.
Focused Alpha first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Focused Alpha held 983 shares of Eli Lilly worth $1.14M as of Q3 2026.
- Focused Alpha bought 577 Eli Lilly shares in Q3 2026, an estimated $681K.
- Eli Lilly made up 0.28% of Focused Alpha's portfolio in Q3 2026, its #60 holding.
- Focused Alpha first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.